I agree, we're spread way to thin with our financial limitations until a source of revenue is established. That $25m infusion we got a short while back could have been stretched to last long enough to get possibly Covid or HIV treatments to fruition. Not if we don't hit paydirt in the next few months it's back to dilutive methods.